Dodick D, Smith T, Cady R et al. Eptinezumab Demonstrates Early Relief from Episodic and Chronic Migraine: Consistency of Effect Across 4 Clinical Trials. AAN 2019, S17.004.
MS-patiënten hebben geen verhoogde kans op COVID-19
nov 2020 | Multipele Sclerose